Q32 Bio (QTTB) Other Accumulated Expenses (2017 - 2023)

Q32 Bio has reported Other Accumulated Expenses for 7 years, with the latest figure at $205000.0 in Q3 2023.

• For the quarter ending Q3 2023, Other Accumulated Expenses fell 59.41% year-over-year to $205000.0; the trailing twelve-month figure through Sep 2023 stood at $205000.0 (down 59.41% YoY), and the FY2022 full-year result was $2.3 million, up 3.19% from the prior year.
• Other Accumulated Expenses for Q3 2023 stood at $205000.0, down from $12.6 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $12.6 million in Q2 2023, with the low at $204000.0 in Q4 2020.
• Average Other Accumulated Expenses over 5 years is $2.6 million, with a median of $1.4 million recorded in 2019.
• Peak annual rise in Other Accumulated Expenses reached 975.0% in 2021, while the deepest fall reached 88.68% in 2021.
• Tracing QTTB's Other Accumulated Expenses over 5 years: stood at $256000.0 in 2019, then slipped by 20.31% to $204000.0 in 2020, then soared by 975.0% to $2.2 million in 2021, then grew by 3.19% to $2.3 million in 2022, then sank by 90.94% to $205000.0 in 2023.
• The last three Other Accumulated Expenses figures came in at $205000.0 (Q3 2023), $12.6 million (Q2 2023), and $9.2 million (Q1 2023), per Business Quant data.

Peer Comparison